Effect of pregnenolone-16α-carbonitrile and dexamethasone on acetaminophen-induced hepatotoxicity in mice

https://doi.org/10.1016/0041-008X(92)90323-KGet rights and content

Abstract

Recently, we demonstrated that a microsomal enzyme inducer with a steroidal structure, pregnenolone-16α-carbonitrile (PCN), markedly decreased the hepatotoxicity of acetaminophen (AA) in hamsters. Therefore, it was of interest to determine if PCN, as well as another steroid microsomal enzyme inducer, dexamethasone (DEX), would decrease the toxicity of AA in mice, another species sensitive to AA hepatotoxicity. Mice were pretreated with PCN or DEX (100 and 75 mg/kg, ip, for 4 days, respectively) and were given AA (300–500 mg/kg, ip). Twenty-four hours after AA administration, liver injury was assessed by measuring serum activities of sorbitol dehydrogenase and alanine aminotransferase and by histopathological examination. Neither PCN nor DEX protected markedly against AA hepatotoxicity in mice; PCN tended to decrease AA-induced hepatotoxicity, whereas DEX was found to enhance AA-induced hepatotoxicity and it produced some hepatotoxicity itself. DEX decreased the glutathione concentration (36%) in liver and increased the biliary excretion of AA-GSH, which reflects the activation of AA, whereas PCN produced neither effect. Thus, whereas PCN has been shown to markedly decrease the hepatotoxicity of AA in hamsters, apparently by decreasing the isoform of P450 responsible for activating AA to N-acetyl-p-benzoquinoneimine, this does not occur in mice after induction with either PCN or DEX. In contrast, DEX enhances AA hepatotoxicity apparently by decreasing liver GSH levels and increasing the activation of AA to a cytotoxic metabolite.

References (47)

  • J.O. Miners et al.

    Mechanism of action of paracetamol protective agents in mice in vivo

    Biochem. Pharmacol.

    (1984)
  • E.T. Morgan et al.

    Comparison of six rabbit liver cytochrome P450 isozymes in formation of a reactive metabolite of acetaminophen

    Biochem. Biophys. Res. Commun.

    (1983)
  • B. Tuchweber et al.

    Effect of phenobarbital or pregnenolone 16α-carbonitrile (PCN) pretreatment on acute carbon tetrachloride hepatotoxicity in rats

    Biochem. Pharmacol.

    (1974)
  • M. Black

    Acetaminophen hepatotoxicity

    Annu. Rev. Med.

    (1984)
  • L.M. Bornheim et al.

    Selective inactivation of mouse liver cytochrome P-450 IIIA by cannabidiol

    Mol. Pharmacol.

    (1990)
  • E.M. Boyd et al.

    Liver necrosis from paracetamol

    Br. J. Pharmacol. Chemother.

    (1966)
  • H.W. Chalkeley

    Method for quantitative morphologic analysis of tissues

    J. Natl. Cancer Inst.

    (1943)
  • B.B. Coldwell et al.

    Metabolism of 14C-acetaminophen in humans and laboratory animals

  • G.B. Corcoran et al.

    Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinoneimine

    Mol. Pharmacol.

    (1980)
  • D.C. Dahlin et al.

    N-acetyl-p-benzoquinoneimine: A cytochrome P-450 mediated oxidation product of acetaminophen

  • D.G. Davidson et al.

    Acute liver necrosis following overdose of paracetamol

    Br. Med. J.

    (1966)
  • Z. Gregus et al.

    Species variation in toxication and detoxication of acetaminophen in vivo: A comparative study of biliary and urinary excretion of acetaminophen metabolites

    J. Pharmacol. Exp. Ther.

    (1988)
  • Z. Gregus et al.

    Effect of microsomal enzyme inducers on biliary and urinary excretion of acetaminophen metabolites in rats: Decreased hepatobiliary and increased hepatovascular transport of acetaminophen-glucuronide after microsomal enzyme induction

    Drug Metab. Dispos.

    (1990)
  • Cited by (35)

    • Activation of GR but not PXR by dexamethasone attenuated acetaminophen hepatotoxicities via Fgf21 induction

      2017, Toxicology
      Citation Excerpt :

      NAPQI covalently binds to mitochondrial proteins and triggers mitochondrial dysfunction, ATP depletion, and oxidative stress (Jaeschke et al., 2010a, 2010b). Previous reports showed that glucocorticoid exposure worsened acetaminophen-induced liver injury in vivo (Madhu et al., 1992; Masson et al., 2010). This aggravation of acetaminophen-induced liver injury by DEX is mainly observed at relatively higher doses of DEX exposure, such as 50 mg/kg, and is primarily mediated by transcriptional induction of Cyp3a11 and glutathione depletion.

    • An updated review on drug-induced cholestasis: Mechanisms and investigation of physicochemical properties and pharmacokinetic parameters

      2013, Journal of Pharmaceutical Sciences
      Citation Excerpt :

      Drugs that act as nuclear receptor activators (e.g., rifampicin, dexamethasone) can increase the clearance of other drugs or induce the formation of reactive metabolites that can cause hepatotoxicity. For example, acetaminophen liver toxicity was exacerbated by increased Phase I-mediated oxidation to the reactive metabolite N-acetyl-p-benzoquinone-imine by CYP inducers.90,91 Several anticholestatic compounds such as UDCA, phenobarbital, and rifampicin are nuclear receptor agonists, which could explain their anticholestatic properties.

    • Acute liver toxicity due to methylprednisolone: Consider this diagnosis in the context of autoimmunity

      2013, Clinics and Research in Hepatology and Gastroenterology
      Citation Excerpt :

      Similar mechanisms of action may be suggested for methylprednisolone or prednisolone, although no experimental proof has been made in mouse or human hepatocytes [27,28]. Dexamethasone could also be a contributing factor for paracetamol-induced hepatitis by reducing the reserves of glutathione and increasing the NADPQI level [29,30]. Other possible toxic or protective roles have been attributed to corticosteroids: increased methotrexate liver toxicity [31], inhibition of hepatocyte regeneration [32], and, conversely, hepatic protection [33].

    • Phagocytes

      2010, Comprehensive Toxicology, Second Edition
    • Regulation of nuclear factor-κB, activator protein-1, and glutathione levels by tumor necrosis factor-α and dexamethasone in alveolar epithelial cells

      2000, Biochemical Pharmacology
      Citation Excerpt :

      Furthermore, it has been shown that the modulation of γ-GCS-HS gene expression by TNF-α and dexamethasone occurs by a mechanism involving c-Jun homodimer [38, 56, 61]. Depletion of liver GSH in mice and inhibition of GSH synthesis by dexamethasone have been observed in rat hepatic cells [73, 74]. Inhaled corticosteroid such as beclomethasone dipropionate decreased erythrocyte GSH levels in patients with asthma [75].

    View all citing articles on Scopus

    This work supported by USPHS Grant ES-03192.

    2

    Supported by USPHS Training Grant ES-07079. Current address: Searle Research & Development, 4901 Searle Parkway, Skokie, IL 60077.

    View full text